Topics

Blurring the Lines of Migraine Treatment: An In-Depth Interview With Richard B. Lipton, MD

20:00 EDT 9 Oct 2019 | Neurology Times

New classes of acute migraine therapies on the cusp of FDA approval look to fill in long-standing gaps in care.

Original Article: Blurring the Lines of Migraine Treatment: An In-Depth Interview With Richard B. Lipton, MD

NEXT ARTICLE

More From BioPortfolio on "Blurring the Lines of Migraine Treatment: An In-Depth Interview With Richard B. Lipton, MD"

Quick Search

Relevant Topic

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...